Sign In
Buy SYK
$335.96
-5.24 (-1.54%)
At Close: Aug 04, 2026
Stryker announces Allan Golston will retire from Board of Directors
04:05pm, Monday, 10'th Feb 2025
Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for
Sales Growth, Strategic Acquisitions Drive Stryker Higher
04:34pm, Friday, 31'st Jan 2025
Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.
Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch
08:36am, Thursday, 30'th Jan 2025
As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
01:48pm, Wednesday, 29'th Jan 2025
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
01:48pm, Wednesday, 29'th Jan 2025
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business
12:36pm, Wednesday, 29'th Jan 2025
SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.
SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans
12:11pm, Wednesday, 29'th Jan 2025
SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
09:34pm, Tuesday, 28'th Jan 2025
Stryker Corporation (NYSE:SYK ) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neur
Stryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Tuesday, 28'th Jan 2025
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates
06:15pm, Tuesday, 28'th Jan 2025
Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago.
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices
05:33pm, Tuesday, 28'th Jan 2025
Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.
Overlooked Stock: SYK
04:45pm, Tuesday, 28'th Jan 2025
Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry
Stryker reports 2024 operating results and 2025 outlook
04:05pm, Tuesday, 28'th Jan 2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024:
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
04:05pm, Tuesday, 28'th Jan 2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decis
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Vi
